WeVote

Bill

Bill

SB 802

AN ACT CONCERNING A COMPASSIONATE MEDICAID WAIVER PROGRAM FOR CHILDREN WITH RARE, PROGRESSIVE OR NEURODEGENERATIVE DISORDERS.

2025 Regular Session Introduced by Christine Cohen and 1 co-sponsor

Connecticut proposes creating a Medicaid waiver program enabling children with rare neurodegenerative disorders to access home and community-based care instead of institutional placement.

REF. TO JOINT COMM. ON Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 802

Legislative bill overview

SB 802 proposes establishing a Medicaid waiver program in Connecticut specifically designed to serve children with rare, progressive, or neurodegenerative disorders. The bill would create pathways for these children to access services outside traditional Medicaid constraints, potentially including home and community-based care options that might otherwise be unavailable or require institutional placement.

Why is this important

Rare and progressive neurological conditions in children often require specialized, intensive care that standard Medicaid coverage may not adequately address. A targeted waiver program could enable families to keep children at home while accessing necessary medical support, potentially improving quality of life and reducing costs associated with institutional care placements.

Potential points of contention

  • Fiscal impact and funding source: The bill's cost to the state is unclear. Medicaid waivers require federal approval and state matching funds; critics may question affordability or whether resources should be allocated differently within existing Medicaid programs.
  • Eligibility definition and scope creep: The terms "rare," "progressive," and "neurodegenerative" require precise medical definitions to prevent either denying eligible children access or expanding coverage beyond intended parameters.
  • Implementation feasibility: Creating a new waiver program requires federal CMS approval, provider infrastructure development, and care coordination systems—timelines and execution challenges could delay access for intended beneficiaries.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.